Mark J. Suto
Impact in
- Molecular Biology top 5%
- Chemical Synthesis and Analysis
- Wnt/β-catenin signaling in development and cancer
- Cancer therapeutics and mechanisms
- Cancer-related gene regulation
- RNA Interference and Gene Delivery
- Cancer Research top 5%
Papers in
-
- Cancer therapeutics and mechanisms 9
- Chemical Synthesis and Analysis 8
- RNA Interference and Gene Delivery 4
-
- Synthesis and Biological Evaluation 6
- Synthesis and biological activity 5
- Co-authors
- Joanne E. Murphy-Ullrich (4 shared papers)Yonghe Li (4 shared papers)Taj D. King (2 shared papers)William R. Turner (7 shared papers)Wei Zhang (5 shared papers)Judith S. Sebolt–Leopold (7 shared papers)Indira Padmalayam (3 shared papers)Moorthy S. S. Palanki (7 shared papers)
- Journals
- Journal of Medicinal Chemistry (13 papers)Tetrahedron Letters (6 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Oncotarget (3 papers)Annual reports in medicinal chemistry (3 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Mark J. Suto
90 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 1.6k
- Cancer Research 313
- Oncology 527
- Organic Chemistry 590
- Physiology 61
Countries citing papers authored by Mark J. Suto
This map shows the geographic impact of Mark J. Suto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Suto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Suto more than expected).
Fields of papers citing papers by Mark J. Suto
This network shows the impact of papers produced by Mark J. Suto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Suto. The network helps show where Mark J. Suto may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Suto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 247 | |
| 2 | 2017 | 243 | |
| 3 | 1988 | 118 | |
| 4 | 2011 | 118 | |
| 5 | Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase. | 1991 | 98 |
| 6 | 1997 | 95 | |
| 7 | 1992 | 92 | |
| 8 | 2020 | 87 | |
| 9 | 2015 | 80 | |
| 10 | 1990 | 79 | |
| 11 | 1997 | 79 | |
| 12 | 2000 | 78 | |
| 13 | 2017 | 69 | |
| 14 | 2016 | 64 | |
| 15 | 2013 | 55 | |
| 16 | 1993 | 54 | |
| 17 | 2016 | 53 | |
| 18 | 2018 | 43 | |
| 19 | 2017 | 42 | |
| 20 | 2011 | 41 |
About Mark J. Suto
Mark J. Suto is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cancer Research and Pharmacology, having authored 93 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Chemical Synthesis and Analysis (8 papers), NF-κB Signaling Pathways (7 papers), Synthesis and Biological Evaluation (6 papers), Cytokine Signaling Pathways and Interactions (5 papers), Synthesis and biological activity (5 papers), RNA Interference and Gene Delivery (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Molecular Biology (1.6k citations), Cancer Research (313 citations), Oncology (527 citations), Organic Chemistry (590 citations) and Physiology (61 citations). Mark J. Suto has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Joanne E. Murphy-Ullrich, Yonghe Li, Taj D. King, William R. Turner, Wei Zhang, Judith S. Sebolt–Leopold, Indira Padmalayam, Moorthy S. S. Palanki, A. J. Solo and Lynn J. Ransone. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters, Bioorganic & Medicinal Chemistry Letters, Oncotarget and Annual reports in medicinal chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.